Passer au contenu principal
eCampus
  • Accueil
  • Outils
    Portfolio Mahara Wooclap
  • Tutoriels
    bientôt disponible !
  • Informations Piratage
    Procédure pour les enseignants de l'Université FAQ sur le site de l'Université
  • Plus
Français ‎(fr)‎
English ‎(en)‎ Español - Internacional ‎(es)‎ Français ‎(fr)‎
Vous êtes connecté anonymement
Connexion
Accueil Outils Replier Déplier
Portfolio Mahara Wooclap
Tutoriels Replier Déplier
bientôt disponible !
Informations Piratage Replier Déplier
Procédure pour les enseignants de l'Université FAQ sur le site de l'Université
  1. M1 D2HP 24-25
  2. TU 08: Biotechnology (S1)
  3. Quality Control of therapeutic proteins

Quality Control of therapeutic proteins

Conditions d’achèvement
    • acidic and basic variants analysis of monoclonal antibodies by IEX-HPLCacidic and basic variants analysis of monoclonal antibodies by IEX-HPLC
      • Agilent publication 2.pdfAgilent publication 2.pdf
      • Bai et al., 2000.pdfBai et al., 2000.pdf
      • fekete 2015.pdffekete 2015.pdf
      • SUPPOR~1.PPTSUPPOR~1.PPT
      • zhang2013.pdfzhang2013.pdf
    • Capillary Gel electrophoresis for identity and purity control of therapeutic proteinsCapillary Gel electrophoresis for identity and purity control of therapeutic proteins
      • Bhimwal et al., 2022.pdfBhimwal et al., 2022.pdf
      • ce-SDS-analysis-therapeutic-proteins.pdfce-SDS-analysis-therapeutic-proteins.pdf
      • Hajba et al., 2023 from page 1 to 5.pdfHajba et al., 2023 from page 1 to 5.pdf
      • IntroductiontoCapillaryElectrophoresisVol-I page 21.pdfIntroductiontoCapillaryElectrophoresisVol-I page 21.pdf
      • SUPPORTING SLIDES - ORAL PRESENTATION- CGE-2024.pptxSUPPORTING SLIDES - ORAL PRESENTATION- CGE-2024.pptx
    • control of secondary Structure of therapeutic proteinscontrol of secondary Structure of therapeutic proteins
      • AN52985-protein-secondary-structure-elucidation-FTIR-spectroscopy.pdfAN52985-protein-secondary-structure-elucidation-FTIR-spectroscopy.pdf
      • cerasolini 2014-Temperature denaturation and aggregation of a multi-domain IGG by biophysical methods.pdfcerasolini 2014-Temperature denaturation and aggregation of a multi-domain IGG by biophysical methods.pdf
      • Siligardi-Hussain2015_Protocol_CDSpectroscopyAnEssentialToolF.pdfSiligardi-Hussain2015_Protocol_CDSpectroscopyAnEssentialToolF.pdf
      • SUPPORTING SLIDES - ORAL PRESENTATION- Circular dichroism 2024.pptxSUPPORTING SLIDES - ORAL PRESENTATION- Circular dichroism 2024.pptx
    • Detection of chemical-degradation variants of therapeutic proteins by RP-HPLCDetection of chemical-degradation variants of therapeutic proteins by RP-HPLC
      • AmershamRPCManual RP HPLC Theory.pdfAmershamRPCManual RP HPLC Theory.pdf
      • Fagan 2024.pdfFagan 2024.pdf
      • kim 2015.pdfkim 2015.pdf
      • lorbetskie 2022.pdflorbetskie 2022.pdf
      • SUPPORTING SLIDES - ORAL PRESENTATION- RP-HPLC- 2024 (1).pptxSUPPORTING SLIDES - ORAL PRESENTATION- RP-HPLC- 2024 (1).pptx
    • N-glycan mapping of therapeutic glycoproteins by HILIC-HPLCN-glycan mapping of therapeutic glycoproteins by HILIC-HPLC
      • kmab-glycan analysis of therapeutic proteins- Zhang L 2016.pdfkmab-glycan analysis of therapeutic proteins- Zhang L 2016.pdf
      • Planinc 2016-ACA-Glycan characterization of biopharmaceuticals-Updates and perspectives.pdfPlaninc 2016-ACA-Glycan characterization of biopharmaceuticals-Updates and perspectives.pdf
      • SUPPORTING SLIDES FOR PREPARING THE ORAL PRESENTATION- Glycan profiling 2024.pptxSUPPORTING SLIDES FOR PREPARING THE ORAL PRESENTATION- Glycan profiling 2024.pptx
    • Peptide mapping of therapeutic proteins by RP-HLC as an identity controlPeptide mapping of therapeutic proteins by RP-HLC as an identity control
      • bobaly et al., 2017.pdfbobaly et al., 2017.pdf
      • Bongers et al., 2000.pdfBongers et al., 2000.pdf
      • focus on peptide mapping , analytical condition and mechanism.pdffocus on peptide mapping , analytical condition and mechanism.pdf
      • Garnik et al., 1988.pdfGarnik et al., 1988.pdf
      • SUPPORTING SLIDES - ORAL PRESENTATION- peptide mapping 2024.pptxSUPPORTING SLIDES - ORAL PRESENTATION- peptide mapping 2024.pptx
    • Purity control of therapeutic proteins by size exclusion chromatography (SEC-HPLC)Purity control of therapeutic proteins by size exclusion chromatography (SEC-HPLC)
      • berkowitz2020.pdfberkowitz2020.pdf
      • Biopharmaceuticals - SEC.pdfBiopharmaceuticals - SEC.pdf
      • Fekete 2014.pdfFekete 2014.pdf
      • hall2018.pdfhall2018.pdf
      • SUPPOR~1.PPTSUPPOR~1.PPT
    • SDS-PAGE for purity and identity controls of therapeutic proteinsSDS-PAGE for purity and identity controls of therapeutic proteins
      • reichel et al., 2013.pdfreichel et al., 2013.pdf
      • roy kumar 2014.pdfroy kumar 2014.pdf
      • SILVAE~1.PDFSILVAE~1.PDF
      • SUPPORTING SLIDES - ORAL PRESENTATION- SDS 2024 (1).pptxSUPPORTING SLIDES - ORAL PRESENTATION- SDS 2024 (1).pptx
    • QC biopharmaceuticals -M1-2024-MT3-17 oct 2024.pdfQC biopharmaceuticals -M1-2024-MT3-17 oct 2024.pdf
◄ Thrombosis
documents ►
Vous êtes connecté anonymement (Connexion)
Obtenir l’app mobile
Politiques
Fourni par Moodle

eCampus

Université Paris-Saclay 7
  • UPSaclay
  • UEVE
  • UVSQ
  • Centrale Supélec
  • École Normale Supérieure
  • Institut d'Optique
  • AgroParisTech
Institut Polytechnique de Paris 3
  • ENSTA
  • Télécom Paris

Université européenne EUGLOH

Assistance

  • Problèmes de connexion
  •  
  • Obtenir l'app mobile

Informations légales

  • Accessibilité numérique
  • Politique de confidentialité
Nouveautés